GlassScriptPhysician profile
Mayank Yadav
NPI 1134535396
$6,953.91
in general payments reported to CMS, 2019-2025
16 companies · $2,897 in 2025
The $2,897 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.13 · 2022: $1,256 · 2023: $2,154 · 2024: $627 · 2025: $2,897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,305 · Food and Beverage: $2,274 · Grant: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,304.65 |
| Food and Beverage | $2,273.87 |
| Grant | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,456.48 | 2022-2025 | Corevalve Evolut R, Abre, Venaseal |
| Abbott Laboratories | $603.42 | 2024-2025 | Tendril, Quadra Assura, Aveir |
| Boston Scientific Corporation | $368.40 | 2022-2024 | Varithena Administration Pack |
| Terumo Medical Corporation | $269.83 | 2022 | |
| Abiomed | $269.36 | 2025 | |
| Novartis Pharmaceuticals Corporation | $203.14 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $195.24 | 2022 | |
| Cardiovascular Systems INC. | $140.19 | 2022 | |
| Novo Nordisk INC | $121.87 | 2022 | |
| Biotronik INC. | $93.43 | 2022 | |
| Merck Sharp & Dohme LLC | $78.41 | 2022-2024 | Verquvo |
| Sanofi-Aventis U.S. LLC | $40.85 | 2023 | |
| Glaxosmithkline, LLC. | $40.55 | 2021-2023 | Arexvy, Bexsero, Shingrix |
| Philips North America LLC | $36.94 | 2022 | |
| Cvrx, INC. | $21.56 | 2025 | Barostim Neo System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $14.24 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayank Yadav listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.